Susan B. Bressler, MD

Professional Titles

• Julia G. Levy, Ph.D. Professor of Ophthalmology

Primary Academic Title

Professor of Ophthalmology

Background

Centers and Institutes

Wilmer Eye Institute Research

Clinical Trial Keywords

Diabetic Retinopathy; Age-Related Macular Degeneration

Videos

• Dr. Susan B. Bressler | Retina Specialist

Research Interests

Age-Related Macular Degeneration, Clinical trials, Diabetic Retinopathy, Ocular Imaging, Venous Occlusive Disease

PubMed

http://www.ncbi.nlm.nih.gov/pubmed/?term=susan+bressler

Selected Publications

• Diabetic Retinopathy Clinical Research Network:  Relationship between Optical Coherence tomography-measured Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema. (Dr. S. Bressler is a member of the writing team for this report).  Ophthalmology 2007;114:525-536.

• Age-Related Eye Disease Study Research Group: A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss.  AREDS Report No. 8. (Dr. Bressler is a member of the writing team of this paper). Arch Ophthalmol 2001;119:1417-1436.

• Age-Related Eye Disease Study Research Group: Potential public health impact of AREDS Results: AREDS report No. 11. (Dr. Bressler is a member of the writing team of this paper).  Arch Ophthalmol 2003;121:1621-1624.

• Age-Related Eye Disease Study Research Group: Risk factors associated with age-related macular degeneration: A case-control study in the Age-Related Eye Disease Study: AREDS Report No. 3.  Writing team:  Anand R, Bressler SB, Davis MD, Ferris FL, Klein R, Lindblad AS, Milton RC, Sperduto RD. Ophthalmology 2000;107:2224-2232. 

• Age-Related Eye Disease Study Research Group: The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs:  AREDS Report No. 4. (Dr. S. Bressler is a member of this manuscript’s editorial committee).  Am J Ophthalmol 2001;131:167-175.

• Age-Related Eye Disease Study Research Group: The Age-Related Eye Disease Study (AREDS): Design implications. AREDS Report No. 1. (Dr. Bressler is a member of this manuscript’s editorial committee). Controlled Clinical Trials 1999;20:573-600.

• Age-Related Eye Disease Study Research Group: The Age-Related Eye Disease Study: A clinical trial of zinc and antioxidants -- AREDS Report No. 2. (Dr. Bressler is a member of this manuscript’s editorial committee).  J Nutr 2000;130:1516S-1519S.

• Age-Related Eye Disease Study Research Group: The AREDS system for classifying age-related macular degeneration from photographs. AREDS Report No. 6.  (Dr. S. Bressler was a member of the Writing Committee for this report). Am J Ophthalmol 2001;132:668-681. 

• Age-Related Eye Disease Study Research Group: The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. (Dr. S. Bressler is a member of the AREDS group). Arch Ophthalmol 2007;125:671-679. 

• Age-Related Eye Disease Study Research Group:  Mortality in the Age-Related Eye Disease Study:  Associations with ocular disorders and an  intervention of high-dose antioxidants and zinc.  AREDS Report No. 13. (Dr. S. Bressler is a member of the writing team of this report).  Arch Ophthalmol 2004;122;716-726.

• Age-Related Eye Disease Study Research Group:  Risk factors associated with age-related nuclear and cortical cataract: A case control study in the Age-Related Eye Disease Study. AREDS Report No. 5. (Dr. S. Bressler is a member of the Editorial Committee for this paper). Ophthalmology 2001;108:1400-1408.

• AREDS Report No. 23: The Relationship of Dietary w-3 Long-Chain Polyunsaturated Fatty Acid Intake with Incident Age-Related Macular Degeneration. (Dr. Susan Bressler is a member of the AREDS research group). Arch of Ophthal, 2008:126(9):1274-1279.

• AREDS2-HOME Study Research Group. Randomized Trial of the ForeseeHome Monitoring Device for Early Detection of Neovascular Age-Related Macular Degeneration.The HOme Monitoring of the Eye (HOME) Study Design- HOME Study Report Number 1 (Writing Committee: Chew E, Clemons TE, Bressler SB, Elman, MJ; Danis RP, et al.) Contemp Clin Trials.  2014 Feb 13;37(2):294-300. 

• AREDS2-HOME Study Research Group:  Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study.   (Writing Committee: Chew E, Clemons TE, Bressler SB, Elman, MJ; Danis RP, et al.).  Ophthalmology Feb 2014; 12(2), 535-544.

• Bhavsar AR, Ip MS, Glassman AR; DRCRnet and the SCORE Study Groups: The Risk of Endophthalmitis following Intravitreal Triamcinolone Injection in the DRCRnet and SCORE Clinical Trials. (Dr. S Bressler is a co-investigator in the DRCR.net)  Am J Ophthalmol 2007 Sep;144(3):454-456.

• Bhavsar AR, Torres K, Bressler NM, Glassman AR, Jampol LM, Kinyoun JL, for the Diabetic Retinopathy Clinical Research Network (Dr. Bressler served as Vice Chair of the DRCR.net during this project). One Year Results Evaluation Following Short Term Use of Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy. JAMA Ophthalmol. July 2014;132(7):889-890.

• Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, et al: An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International AMD Epidemiological Study Group. Surv Ophthalmol 1995;39:5:367-374.

• Blair MP, Apte R, Bressler NM, Miskala P, Schachat AP, Bressler SB, Goldberg MF: A retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with Verteporfin. Retina 2004;24;501-506.

• Bressler NM and Bressler SB: Preventive Ophthalmology: Age-related macular degeneration.  Ophthalmology 1995;102:1206-1211.

• Bressler NM, Alexander J, Hawkins BS, Maguire MG, Fine SL, Macular Photocoagulation Study Group:  Response to: Subfoveal neovascular lesions in age-related macular degeneration. (Dr. Bressler is a member of the MPS Group). Arch Ophthalmol 1993;111:901.

• Bressler NM, Alexander JA, Bressler SB et al: Subfoveal neovascular lesions in age-related macular degeneration: Guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991;109:1242-1257.

• Bressler NM, Bressler SB, Alexander J, et al: Loculated fluid: A previously undescribed angiographic finding in macular degeneration.  Arch Ophthalmol 1991;109:211-215.  (Although listed as second author, the concept, execution, analysis, and manuscript preparation of this project was equally shared by the first and second author).

• Bressler NM, Bressler SB, Cotch MF, Hawkins BS, Marsh MJ, et al for The Submacular Surgery Trials Pilot Study Investigators: Submacular Surgery Trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. I. Ophthalmic outcomes. SST Pilot Study Report No. 1. (Dr. Bressler was a member of this manuscript’s writing team). Am J Ophthalmol 2000;130:4:387-407.

• Bressler NM, Bressler SB, Fine SL: Age?related macular degeneration. Surv Ophthalmol 1988;32:375?413.

• Bressler NM, Bressler SB, Gragoudas EG: Clinical characteristics of choroidal neovascular membranes. Arch Ophthalmol 1987;105:209?213.

• Bressler NM, Bressler SB, Seddon JS et al: Drusen characteristics in patients with exudative versus non?exudative age?related macular degeneration. Retina 1988;8:109?114.

• Bressler NM, Bressler SB, West S et al: The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol, 1989;107:847?852. 

• Bressler NM, Bressler SB: Photodynamic therapy with Verteporfin (Visudyne): Impact on Ophthalmology and Visual Sciences.  Investigative Ophthalmology and Visual Sciences 2000;41:3;624-628.

• Bressler NM, Edwards AR, Antoszyk AN, Beck, RW, Browning DJ, et al on behalf of the Diabetic Retinopathy Clinical Research Network: Retinal thickness on Stratus(tm) optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol 2008;145:894-901. 

• Bressler NM, Frost L, Bressler SB, Fine SL: Natural course of poorly defined choroidal neovascularization in macular degeneration.  Arch Ophthalmol, 1988;106:1537?1542.

• Bressler NM, Maguire MG, Murphy PL, Alexander J, Margherio R, Schachat AS, Fine SL, Stevens TS, Bressler SB: Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration: Results of a randomized pilot trial.  Arch Ophthalmol 1996;114:1456-1464.

• Bressler NM, Marsh MJ, Maguire MG, Alexander J, Phillips DA, Javornik NB, Heiner CJ, Bressler SB et al for the MPS Group: Occult choroidal neovascularization: Influence on visual outcome in patients with age-related macular degeneration. Arch Ophthalmol 1996;114:400-412.

• Bressler NM, Miller KM, Beck RW, Bressler SB, et al for the Diabetic Retinopathy Clinical Research Network:  Observational study of subclinical diabetic macular edema.  Eye (London) 2012; 26: 833-840.

• Bressler NM, Silva J, Bressler SB, Fine SL, Green WR: Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 1994;14:130-142. 

• Bressler S, Melia M, Glassman A, Almukhtar T, Jampol L, et al for the Diabetic Retinopathy Clinical Research Network.  Ranibizumab Plus Prompt or Deferred Laser for Diabetic Macular Edema in Eyes with Vitrectomy Prior to Anti-Vascular Endothelial Growth Factor Therapy. Retina, May 2015. DOI: 10.1097/IAE.0000000000000617. 

• Bressler SB, Almukhtar T, Aiello LP, et al, for the Diabetic Retinopathy Clinical Research Network:  Green or Yellow Laser Treatment for Diabetic Macular Edema:  Exploratory Assessment within the Diabetic Retinopathy Clinical Research Network.   Retina 2013: 10: 2080-2088.

• Bressler SB, Ayala A, Bressler NM, Melia M, Qin H, et al. for the Diabetic Retinopathy Clinical Research Network.  An Exploratory Analysis of Persistent Macular Thickening Following Intravitreous Ranibizumab for Center-involved Diabetic Macular Edema with Vision Impairment. Submitted to JAMA Ophthalmol 2015.

• Bressler SB, Bressler NM, Fine SL et al: Subfoveal neovascular membranes in senile macular degeneration: Relationship between membrane size and visual prognosis. Retina 1983;3:7?11.

• Bressler SB, Bressler NM, Seddon JS, et al: Interobserver and intraobserver reliability in the clinical classification of drusen. Retina 1988;8:102?108.

• Bressler SB, Bressler NM. Dick Green Tribute.  Retina 2005;25:S1-S28.

• Bressler SB, Jefferys JL, Bressler NM, Alexander J, et al, for the Macular Photocoagulation Study Group: Evaluation of argon green versus krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the Macular Photocoagulation Study.  Arch Ophthalmol 1994;112:1176-1184.

• Bressler SB, Maguire MG, Bressler NM et al: Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol 1990;108:1442?1447.

• Bressler SB, Munoz B, Solomon SD, West SK, and the Salisbury Eye Evaluation (SEE) Study Team:  Racial differences in the Prevalence of age-related macular degeneration:  The Salisbury Eye Evaluation (SEE) Project.  Arch Ophthalmol 2008;126(2):241-245. 

• Bressler SB, Pieramici DJ, Koester MS, Bressler NM for the Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group:  Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation:  Outcomes potentially relevant to management. TAP Report No. 6. (Dr. S. Bressler chaired this writing committee).  Arch Ophthalmol 2004;122;325-329.

• Bressler SB, Qin H, Beck RW, et al for the Diabetic Retinopathy Clinical Research Network:  Factors Associated With Changes in Visual Acuity and Central Subfield Thickness at 1 Year After Treatment for Diabetic Macular Edema With Ranibizumab.  Arch Ophthal 2012; 130(9): 1153-61.

• Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, et al for the Diabetic Retinopathy Clinical Research Network:  Exploratory Analysis of Effect of Intravitreal Ranibizumab or Triamcinolone on Worsening of Diabetic Retinopathy in a Randomized Clinical Trial.  JAMA Ophthalmol 2013;131(8):1033-40.

• Bressler SB, Silva JC, Bressler NM, Alexander JA, Green WR:  Clinicopathologic correlation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol, 1992;110:827-832.

• Bressler, SB: Introduction: Understanding the Role of Angiogenesis and Antiangiogenic Agents in Age-Related Macular Degeneration for Ophthalmology supplement entitled: Update on Treatment of Neovascular Age-Related Macular Degeneration: Focus on Antiangiogenesis in Clinical Practice. Ophthalmology 2009;116(10):S1-S7. 

• Browing DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB etal and the Diabetic Retinopathy Clinical Research Network:  Optical Coherence Tomography measurements and analysis methods in Optical Coherence Tomography studies of diabetic macular edema. Ophthalmology, 2008;115(8)1366-1371.

• Brown JC, Solomon SD, Bressler SB, Schachat AP, DiBernardo C, and Bressler NM:  Detection of diabetic foveal edema:  Contact lens biomicroscopy compared with optical coherence tomography.  Arch Ophthalmol 2004;122;330-335.

• Browning DJ, Altaweel MM, Bressler NM, Bressler SB, Scott IU and the Diabetic Retinopathy Clinical Research Network: Diabetic Macular Edema: What is focal and what is diffuse? Am J Ophthalmol 2008 Nov;146(5):649-55. 

• Browning DJ, Apte RS, Bressler SB, et al and the Diabetic Retinopathy Clinical Research Network.  Association of the Extent of Diabetic Macular Edema as Assessed by Optical Coherence Tomography with Visual Acuity and Retinal Outcome Variables. Retina, 2009;29(3):300-5.

• Burgess DB, Hawkins BS, Jefferys J, Bressler NM, Bressler SB: Macular Photocoagulation Study Group: Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization.  Arch Ophthalmol 1993;111:1189-1199.

• Campbell JP, Bressler SB, Bressler NM:  Impact of Availability of Anti-VEGF Therapy on Vision Impairment and Blindness due to Neovascular AMD.  Arch Ophthal 2012; 130(6):  794-795.

• Chaikitmongkol V, Bressler NM, Bressler SB. Early detection of choroidal neovascularization facilitated with a home monitoring program in age-related macular degeneration. Retin Cases Brief Rep. 2015;9(1):33-7.  

• Chamberlin JA, Bressler NM, Bressler SB, et al: The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. Ophthalmology 1989;1526?1534.

• Chang MA, Bressler SB, Munoz B, West S:  Racial Differences and other Risk Factors for Incidence and Progression of Age-Related Macular Degeneration: Salisbury Eye Evaluation (SEE) Project. Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2395-402. 

• Chang MA, Bressler SB: Photodynamic Therapy for Chronic Pigment Epithelial Detachment in Central Serous Chorioretinopathy. Canadian Journal of Ophthalmology, 2009;44(2)221-222.

• Chang MA, Do DV, Bressler SB, Cassard SD, Gower EW and Bressler NM: Prospective 1-Year Study of Ranibizumab for Predominantly Hemorrhagic Chorodial Neovascular Lesions in Age-Related Macular Degeneration. Retina 2010 Sep; 30 (8):1171-1176. 

• Chang MA, Fine HF, Bass E, Bressler SB, Schachat AP, Solomon SD, Bressler NM: Patients' preferences in choosing therapy for retinal vein occlusions. Retina 2007 Jul-Aug;27(6):789-97.

• Charkoudian LD, Gower EW, Solomon SD, Schachat AP, Bressler NM, Bressler SB: Vitamin Usage Patterns in the Prevention of Advanced Age-Related Macular Degeneration.  Ophthalmology 2008;115(6):1032-1038. 

• Chew EY, Sperduto RD, Milton RC, Clemmons TE, Gensler GR, Bressler SB et al : Risk of Advanced Age-related Macular Degeneration Following Cataract Surgery in the Age-Related Eye Disease Study. AREDS Report 25. Ophthalmology 2009:116(2)297-303.

• Childs AL and the Submacular Surgery Trials Patient-Centered Outcomes Subcommittee for the Submacular Surgery Trials Pilot Study Investigators:  Responsiveness of the SF-36 Health Survey to changes in visual acuity among patients with subfoveal choroidal neovascularization. (Dr. S. Bressler is an SST Pilot Study Investigator).  Am J Ophthalmol 2004;173:373 - 375.

• Clemens TE, Chew EY, Bressler SB, McBee W for the AREDS Research Group:  National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS).  Report No. 10.  Arch Ophthalmol 2003;121:211-217.

• Complications of Age-Related Macular Degeneration Prevention Trial Research Group: The Complications of Age-Related Macular Degeneration Prevention Trial: Laser treatment in patients with bilateral large drusen. (Dr. S. Bressler is a member of the CAPT Research Group). Ophthalmol 2006;113:1974-1986.

• Cukras C, Agron E, Klein M, Ferris FL, et. al for the Age-Related Eye Disease Study Research Group.  Natural History of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration: Age-Related Eye Disease Study Report No, 28:   Ophthalmology 2010; 117(3):489-499. (Dr. Susan Bressler is a member of the AREDS research group.)

• Danis RP, Scott IU, Bressler SB, Bressler NM, Browning DJ and the Diabetic Retinopathy Clinical Research Network Study Group: Association of Fluorescein Angiographic Features with Visual Acuity and with Optical Coherence Tomographic and Stereoscopic Color Fundus Photographic Features of Diabetic Macular Edema in a Randomized Clinical Trial.  Retina. Nov-Dec 2010;30(10):1627-37.

• Dastgheib K, Bressler SB, Green WR: Clinicopathologic correlation of laser lesion expansion following treatment of choroidal neovascularization. Retina 1993;13:345-352.

• Davis MD, Bressler SB, Aiello LP, Bressler NB et al and the Diabetic Retinopathy Clinical Research Network Study Group: Comparison of Time-Domain OCT and Fundus Photographic Assessments of Retinal Thickening in eyes with Diabetic Macular Edema. Invest Ophthalmol Vis Sci 2008;49:1745-1752. 

• Diabetic Retinopathy Clinical Research Network (Dr. Bressler served as Vice Chair of the DRCR.net during this project):  Macular Edema After Cataract Surgery in Eyes Without Pre-operative Central-involved Diabetic Macular Edema.   JAMA Ophthalmol. 2013; 131(7): 870-879. 

• Diabetic Retinopathy Clinical Research Network (Dr. Bressler served as Vice Chair of the DRCR.net during this trial):  Randomized Clinical Trial Evaluating Intravitreal Ranibizumab or Saline for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy.  JAMA Ophthalmol. 2013; 131(3):283-293.  

• Diabetic Retinopathy Clinical Research Network (Dr. Bressler served as Vice Chair of the DRCR.net during this trial):  Three-Year Follow-up of a Randomized Trial Evaluating Ranibizumab Plus Prompt versus Deferred Laser for Diabetic Macular Edema.  Ophthalmology 2012 Dec; 119(11): 2312-18.

• Diabetic Retinopathy Clinical Research Network Writing Committee on behalf of the DRCR.net (Dr.  Bressler served as a Vice Chair of the DRCR.net during this project):  Rationale for the Diabetic Retinopathy Clinical Research Network Treatment Protocol for Center-Involved Diabetic Macular Edema.  Ophthalmology 2011 Dec; 118 (12):  e5-e14.   

• Diabetic Retinopathy Clinical Research Network Writing Committee on behalf of the DRCR.net. Vitrectomy Outcomes in Eyes with Diabetic Macular Edema and Vitreomacular Traction. (Dr. Bressler is a Vice Chair of the DRCR.net) Ophthalmology. 2010 Jun;117(6):1087-1093.

• Diabetic Retinopathy Clinical Research Network Writing Committee on behalf of the DRCR.net.  Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema.  (Dr. Bressler is a Vice Chair of the DRCR.net.) Ophthalmology 2011 April: 118(4): 609-614.  

• Diabetic Retinopathy Clinical Research Network. (Writing Committee: Chalam KV, Bressler SB, Edwards AR, et al)  Retinal Thickness in People with Diabetes and Minimal or No Diabetic Retinopathy:  Heidelberg Spectralis Optical Coherence Tomography.  IOVS Dec 2012; 53(13):  8154-61.  

• Diabetic Retinopathy Clinical Research Network. Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema. (Dr. S Bressler is a co-investigator in the DRCR.net)  Ophthalmology 2008 Sep;115(9):1447-1459.e10

• Diabetic Retinopathy Clinical Research Network.  (Writing Committee:  Bressler SB, Baker CW, Almukhtar T, Bressler NM, Glassman AR et al):  A Pilot Study of Individuals with Diabetic Macular Edema undergoing Cataract Surgery. JAMA Ophthalmol.  2014; 132(2): 224-226.    

• Diabetic Retinopathy Clinical Research Network: A Phase 2 Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema. (Dr. S Bressler is a co-investigator in the DRCR.net)  Ophthalmology 2007;114(10):1860-1867.

• Diabetic Retinopathy Clinical Research Network: Comparison of the modified-ETDRS and mild macular grid laser photocoagulation strategies for diabetic macular edema.  (Dr. S Bressler is a co-investigator in the DRCR.net)   Arch Ophthalmol 2007;125:469-480.

• Diabetic Retinopathy Clinical Research Network: Diurnal Variation in Retinal Thickening Measurement by Optical Coherence Tomography in Center-Involved Diabetic Macular Edema. (Dr. S Bressler is a co-investigator in the DRCR.net)   Arch Ophthalmol 2006 Dec;124(12):1701-7.

• Diabetic Retinopathy Clinical Research Network: Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study. (Dr. S Bressler is a co-investigator in the DRCR.net)  Ophthalmology 2007 Jun;114(6):1190-6.

• Diabetic Retinopathy Clinical Research Network: Reproducibility of Macular Thickness and Volume Using Zeiss Optical Coherence Tomography in Patients with Diabetic Macular Edema.  (Dr. S Bressler is a co-investigator in the DRCR.net)  Ophthalmology 2007 Aug;114(8):1520-5.

• Diabetic Retinopathy Clinical Research Network: Three-year Followup of a Randomized Trial Comparing Focal/Grid Photocoagulation and Intravitreal Triamcinolone for Diabetic Macular Edema (Dr. Susan Bressler is a Vice Chair of the DRCR.net).  Arch Ophthalmol, 2009: 127(3)245-251.

• DiLoreto DA, Bressler, NM, Bressler SB, Schachat AP: Best and final visual acuity in ophthalmologic research.  Arch Ophthalmol 2003;121:1586-1590.

• Do D, Bressler S, Cassarde S, Gower E, Tabandeh H, et al:  Ranibizumab for Macular Telangiectasia Type 2 in the Absence of Subretinal Neovascularization.  Retina Oct 2014;(34)10:2063-2071.

• Do DV, Bressler NM, Bressler SB: Large Submacular hemorrhages  after verteporfin therapy.  Am J Ophthalmol 2004;137: 558-560.

• Do DV, Gower EW, Boyer D, Bressler N, Bressler S, et al for the AMD DOC Study Group:  Detection of New Onset Choroidal Neovascularization using Optical Coherence Tomography:  the AMD DOC Study.  Ophthalmology 2012 Apr; 119 (4):  771-778.

• Do DV, Nguyen QD, Bressler NM, Schachat AP, Solomon SD, Melia M, Bressler SB: Hemoglobin a1c awareness among patients receiving eye care at a tertiary ophthalmic center.  Am J Ophthalmol 2006;141(5):951-953. 

• Dong LM, Stark WJ, Jefferys JL, Al-Hazzaa S, Bressler SB, Solomon SD, Bressler NM: Progression of Age-related Macular Degeneration after Cataract Surgery. Arch Ophthalmol, 2009;127(11):1412-1419.

• Duncan DD, Munoz B, Bandeen-Roche K, West SK, and Salisbury Eye valuation Project Team: Assessment of ocular exposure to ultraviolet-B for population studies. (Dr. Bressler is a member of The SEE Project Team). Photochem and Photobiol 1997;66[5]:701-709. 

• Duncan DD, Munoz B, Bandeen-Roche K, West SK, and the Salisbury Eye Evaluation Project Team: Visible and ultraviolet-B ocular-ambient exposure ratios for a general population. (Dr. Bressler is a member of The SEE Project Team). Invest Ophthalmol Vis Sci 1997;38:5:1003-1011. 

• Duncan DD, Schneider W, West KJ, Kirkpatrick SJ, West SK, and the Salisbury Eye Evaluation Project Team: The development of personal dosimeters for use in the visible and ultraviolet wavelength regions. (Dr. Bressler is a member of The SEE Project Team).  Photochem Photbiol 1995;62:94-100. 

• Dyer DS, Brant AM, Schachat AP, Bressler SB, Bressler NM: Angiographic features and outcome of questionable recurrent choroidal neovascularization.  Am J Ophthalmol 1995;120(4):497-505.

• Edwards MG, Schachat AP, Bressler SB, Bressler NM: Outcome of cataract surgery performed to permit diagnosis, determine eligibility for laser therapy, or perform laser therapy of retinal disorders. Am J Ophthalmol, 1994;118(4):440-444.

• Elman M, Ayala A, Bressler N, Browning D, Flaxel C, et al for the Diabetic Retinopathy Clinical Research Network.  Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment:  5-Year Randomized Trial Results (Dr. Bressler served as Vice Chair for the DRCR.net during this trial).  Ophthalmology 2015; 122(2):375-81.

• Elman M, Ayala A, Bressler N, Browning D, Flaxel C, et al for the Diabetic Retinopathy Clinical Research Network.  Topical Nepafenec in Eyes with Non-Central Diabetic Macular Edema.  (Dr. Bressler served as a Vice Chair for the DRCR.net during this trial).  Retina, Feb 2015; 35(5): 944-956.   

• Flaxel CJ, Edwards AR, Aiello LP, Arrigg PA, Beck RW, Bressler NM, Bressler SB, et al:  Factors Associated with Visual Acuity Outcomes after Vitrectomy for Diabetic Macular Edema.  Retina 2010: 30:1488–1495.

• Flaxel CJ, Edwards AR, Aiello LP, Arrigg PA, Beck RW, Bressler NM, Bressler SB, et al:  Factors Associated with Visual Acuity Outcomes after Vitrectomy for Diabetic Macular Edema.  Retina 2010: 30:1488–1495

• Folk JC, Blackhurst DW, Alexander J, Elman MJ, Phillips DA, Macular Photocoagulation Study Group: Pretreatment fundus characteristics as predictors of recurrent choroidal neovascularization. (Dr. Bressler is a member of the MPS Group). Arch Ophthalmol 1991;109:1193-1194. 

• Freeman EE, Munoz B, Bressler SB, West SK: Hormone replacement therapy, reproductive factors, and age-related macular degeneration:  The Salisbury Eye Evaluation Project.   Ophthalmic Epidemiology 2005;12(1):37-46.   

• Gangaputra S,  Almukhtar T, Glassman A,  Aiello LP, Bressler NM, Bressler SB, et al:  Comparison of Film and Digital Fundus Photographs in Eyes of Individuals with  Diabetes Mellitus.  IOVS 2011 Aug; 52:6168-73.  

• Gass JDM, Bressler SB, Akduman L, Olk J, Caskey PJ, Zimmerman LE:  Bilateral idiopathic multifocal retinal pigment epithelium detachments in otherwise healthy middle-aged adults. A clinicopathologic study.  Retina 2005;25:304-310.

• Glassman AR, Beck RW, Browning DJ, Danis RP, Kollman C, for the Diabetic Retinopathy Clinical Research Network Study Group: Comparison of Optical Coherence Tomography Retinal Thickness Measurements in Diabetic Macular Edema with and without Reading Center Manual Grading from a Clinical Trials Perspective. (Dr. Susan Bressler is a Vice Chair of the DRCR.net) IOVS, 2009:20(2)560-566.

• Googe J, Brucker AJ, Bressler NM, Qin H, Aiello LP, Anroszyk A, Beck RW, Bressler SB, et al:  Randomized Trial Evaluating Short-Term Effects of Intravitreal Ranibizumab or Triamcinolone Acetonide on Macular Edema After Focal/Grid Laser For Diabetic Macular Edema in Eyes Also Receiving Panretinal Photocoagulation, Retina 2011 31(6)1009-27.

• Grossniklaus HE, Green WR for the Submacular Surgery Trials Research Group: Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization.  Arch Ophthalmol 1998;116:745-749.

• Grossniklaus HE, Wilson DJ, Bressler SB, Bressler NM, Toth CA, Green WR, Miskala P, for the Submacular Surgery Trials Research Group: Clinicopathologic studies of eyes that were obtained postmortem from four patients who were enrolled in the Submacular Surgery Trials:  SST Report No. 16.  Am J Ophthalmol 2006;141:93-104. 

Honors

• Retina Hall of Fame, 10/4/17
• Gertrude D. Pyron Award for Lifetime Achievement of Outstanding Research, American Society of Retina Specialists (ASRS), 1/1/08
• Goodwin M. Breinin, MD Visiting Professorship, New York University Medical Center, New York, NY, 1/1/08
• Senior Honor Award, The American Society of Retina Specialists, 1/1/08
• Twelfth Irving H. Leopold Lecture, Sinai Hospital, New York, 1/1/07
• Dr. G.V. Simpson Lectureship in Ophthalmology, Annual Clinical Day in Ophthalmology, London, Ontario, Canada, 1/1/05
• The Helen Keller Lecture, University of Alabama at Birmingham, 1/1/04
• Honor Award, The American Society of Retina Specialists, 1/1/04
• The American Academy of Ophthalmology Senior Achievement Award, 1/1/04
• Inaugural Recipient: The Julia G. Levy, PhD. Professor of Ophthalmology, Johns Hopkins University School of Medicine, 1/1/04
• The Krill Lecture, Chicago Ophthalmological Society, Chicago, Illinois, 1/1/03
• First Louisville Academy of Ophthalmology Memorial Lectureship, First Louisville Academy of Ophthalmology, Louisville, Kentucky, 1/1/03
• The Paul Sternberg, Jr. Lectureship, Emory University, Atlanta, Georgia, 1/1/02
• Rosenthal Award, (Macula Society), 1/1/02
• Olga Keith Weiss Scholar, Research to Prevent Blindness, 6/1/98
• Election to membership, Club Jules Gonin Society, 6/1/98
• M. K. Humphries, Jr. Lecturer, University of Virginia Health Sciences Center, 6/1/96
• Honor Award, American Academy of Ophthalmology, 6/1/95
• Faculty Croupier, Monte Carlo Night, Johns Hopkins University School of Medicine, 6/1/95
• Heed/Knapp Fellowship, 6/1/87
• Heed Fellowship, 6/1/86
• Paul Ehrlich Award in Clinical Investigation, Johns Hopkins University School of Medicine, 6/1/82
• Citation for Scholastic Achievement, American Medical Women's Association, 6/1/82
• Alpha Omega Alpha, Johns Hopkins University School of Medicine, 6/1/81
• Summa Cum Laude, Smith College, 6/1/78
• Phi Beta Kappa, 6/1/77
• First Group Scholar, Smith College, 6/1/76
• Dean's List, Smith College, 9/1/75